Pfizer's suffering from generics, but 'innovation for growth'—not big M&A—is still the mantra - FiercePharma

  1. Pfizer's suffering from generics, but 'innovation for growth'—not big M&A—is still the mantra  FiercePharma
  2. Pfizer's earnings outlook disappoints after Viagra loses patent protection and Lyrica faces same fate  CNBC
  3. Pfizer quarterly profit in line, touts pipeline of future products  Yahoo Finance
  4. Pfizer Tops Q4 Earnings But Guides for Weaker 2019 as Lyrica Exclusivity Ends  TheStreet.com
  5. Pfizer's Outlook Disappoints as Drugmaker Focuses on Pipeline  Bloomberg
  6. View full coverage on Google News


from Top stories - Google News http://bit.ly/2G9KLRV

Comments

Popular posts from this blog

Huge PS4 Sale Begins On PSN, Just As The Last One Ended - GameSpot

Razer Game Store to cease operations - Channel NewsAsia

First Look At The Fallout Inspired RPG, The Outer Worlds - GameSpot